Study Overview
Powers et al. (2003) published one of the early comprehensive reviews examining creatine as a dietary supplement, covering its biochemistry, mechanisms of action, performance benefits, and safety profile. This review was instrumental in shaping scientific and public understanding of creatine supplementation during a period when misinformation about the supplement was widespread (ME et al., 2003) .
Key Findings
- Confirmed ergogenic effects: Creatine was shown to consistently enhance performance in high-intensity, short-duration activities including sprinting, weightlifting, and repeated-bout exercise
- Lean mass increases: Supplementation reliably increased lean body mass, attributed to both water retention and genuine muscle protein synthesis enhancement
- Safety profile established: No credible evidence of adverse effects on kidney function, liver function, or hydration status in healthy individuals at recommended doses
- Mechanistic clarity: The review clearly outlined the phosphocreatine energy system and how supplementation increases the intramuscular phosphocreatine pool available for rapid ATP regeneration
- Debunked early myths: Addressed and refuted common myths about cramping, dehydration, and organ damage that had limited creatine adoption
Practical Implications
Powers et al. (2003) helped establish creatine monohydrate as the gold standard supplement for strength and power athletes. The review confirmed that a loading phase of 20g daily for 5-7 days followed by 3-5g daily maintenance is effective and safe. By systematically addressing safety concerns, the review provided a scientific foundation for healthcare professionals to confidently discuss creatine with patients and athletes. The conclusions of this early review have withstood the test of time, with subsequent large-scale reviews and the ISSN position stand reaching similar conclusions with even stronger evidence bases.
Study Limitations
- As a 2003 publication, it predates many subsequent RCTs and meta-analyses that have further strengthened the evidence
- The review had limited data on cognitive and neurological benefits, which were less studied at the time
- Long-term safety data (beyond 5 years) was scarce at the time of publication
- Population-specific effects (women, elderly, vegetarians) were underrepresented in the available literature
Study Design and Methodology
Understanding how a study was designed helps assess the strength of its conclusions. Key methodological factors to evaluate include:
- Sample size — larger studies (n=50+) provide more reliable results than small studies (n=10-15). Small sample sizes increase the risk of false positives and limit the ability to detect moderate effect sizes
- Study duration — creatine research requires adequate duration for muscle saturation (minimum 4 weeks for maintenance dosing, 1 week for loading). Studies shorter than this may miss the full effect
- Blinding — double-blind, placebo-controlled designs (where neither researchers nor participants know who receives creatine) are the gold standard for minimising bias
- Population studied — results from trained athletes may not fully apply to untrained individuals, and vice versa. Age, sex, and dietary habits (particularly vegetarian status) also influence creatine response
- Outcome measures — direct measures (muscle biopsy, MRS imaging) are more informative than indirect proxies (blood markers, performance tests) for assessing creatine uptake and metabolism
Clinical Implications and Practical Relevance
This research contributes to our understanding of creatine in several practical ways:
For athletes and fitness enthusiasts: The findings support the use of creatine monohydrate as a safe, effective ergogenic aid. The standard dosing protocol of 3-5g daily remains well-supported by the cumulative evidence base including this study.
For healthcare professionals: Understanding the specific mechanisms and safety data from studies like this helps clinicians provide evidence-based guidance to patients who ask about creatine supplementation. The research consistently shows a favourable safety profile at recommended doses.
For the Malaysian context: While most creatine research is conducted in Western populations, the fundamental biochemistry (ATP-phosphocreatine system) is universal. Malaysian consumers can apply these findings with confidence, adjusting for local factors like tropical climate (increased hydration needs) and halal dietary requirements (synthetic creatine monohydrate is permissible).
How This Fits Into the Broader Evidence
No single study should be used to make definitive claims about creatine supplementation. Instead, this research should be viewed as one piece of a much larger evidence base:
- The ISSN Position Stand (2017) synthesises hundreds of studies into comprehensive recommendations
- Multiple systematic reviews and meta-analyses confirm creatine’s effects on strength, power, and lean mass
- Long-term safety data spanning up to 5 years shows no adverse effects at recommended doses
For a complete overview of the evidence, explore our Research Library which covers 60+ landmark creatine studies.
Sources & References
This page summarizes Powers et al. (2003). Full citation: Powers ME, Arnold BL, Weltman AL, Perrin DH, Mistry D, Kahler DM, Kraemer W, Volek J. Creatine supplementation increases total body water without altering fluid distribution. Journal of Athletic Training. 2003;38(1):44-50.
What This Means for You
For the average creatine user, this research supports the following practical recommendations:
- Choose creatine monohydrate — it remains the most studied and effective form
- Take 3-5g daily — consistent daily dosing is more important than timing
- Take it with food — insulin response from meals enhances muscle uptake
- Be patient — full saturation takes 3-4 weeks without loading
- Combine with exercise — creatine works best when paired with resistance or high-intensity training
For more on practical dosing strategies, see our creatine dosage guide.